Supplementary Table S1 from RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Wenxin Zheng,Diana Rose E. Ranoa,Xiaona Huang,Yuzhu Hou,Kaiting Yang,Elizabeth C. Poli,Michael A. Beckett,Yang-Xin Fu,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/0008-5472.22426803

2023-01-01

Abstract:<p>Table S1. Shows the enrichment scores of gene sets enriched in tumors with high frequency of DCs</p>

What problem does this paper attempt to address?

Supplementary Table S2 from RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Wenxin Zheng,Diana Rose E. Ranoa,Xiaona Huang,Yuzhu Hou,Kaiting Yang,Elizabeth C. Poli,Michael A. Beckett,Yang-Xin Fu,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/0008-5472.22426800

2023-01-01

Abstract:Table S2. Shows Rank Metric Scores for genes for DsRNA response or RIG-I like receptors Signaling
Supplementary Figures S1 to S6 from RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Wenxin Zheng,Diana Rose E. Ranoa,Xiaona Huang,Yuzhu Hou,Kaiting Yang,Elizabeth C. Poli,Michael A. Beckett,Yang-Xin Fu,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/0008-5472.22426806

2023-01-01

Abstract:Figure S1. describes the apoptotic status of tumor infiltrating and antigen specific CD8+ T cells; Figure S2. describes the apoptotic status and cell surface phenotype of BMDCs; Fig S3. shows an association analysis of LGP2 and overall survival of TNBC and Luminal A patients who received RT; Fig S4. shows correlation analysis between LGP2 expression and clinical outcome of melanoma and sarcoma patients; Figure S5. shows Correlation between gene expression level of LGP2 (DHX58) and signature genes of DCs and CD8+ T cells in human melanoma; Fig S6. shows an association between LGP2 expression and prognosis in pancreatic cancer and colorectal cancers.
RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Wenxin Zheng,Diana Rose E Ranoa,Xiaona Huang,Yuzhu Hou,Kaiting Yang,Elizabeth C Poli,Michael A Beckett,Yang-Xin Fu,Ralph R Weichselbaum,Diana Rose E. Ranoa,Elizabeth C. Poli,Michael A. Beckett,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/0008-5472.can-20-2324

IF: 11.2

2020-10-21

Cancer Research

Abstract:Dendritic cells (DC) play an essential role in innate immunity and radiation-elicited immune responses. LGP2 is a RIG-I-like receptor involved in cytoplasmic RNA recognition and antiviral responses. Although LGP2 has also been linked to cell survival of both tumor cells and T cells, the role of LGP2 in mediating DC function and antitumor immunity elicited by radiotherapy remains unclear. Here, we report that tumor DCs are linked to the clinical outcome of patients with breast cancer who received radiotherapy, and the presence of DC correlates with gene expression of LGP2 in the tumor microenvironment. In preclinical models, host LGP2 was essential for optimal antitumor control by ionizing radiation (IR). The absence of LGP2 in DC dampened type I IFN production and the priming capacity of DC. In the absence of LGP2, MDA5-mediated activation of type I IFN signaling was abrogated. The MDA5/LGP2 agonist high molecular weight poly I:C improved the antitumor effect of IR. This study reveals a previously undefined role of LGP2 in host immunity and provides a new strategy to improve the efficacy of radiotherapy. SIGNIFICANCE: These findings reveal an essential role of LGP2 in promoting antitumor immunity after radiotherapy and provide a new strategy to enhance radiotherapy.

oncology
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Wenhua Sang,Yiduo Zhou,Haiyan Chen,Chengxuan Yu,Lisi Dai,Zhongkun Liu,Lang Chen,Yimin Fang,Panpan Ma,Xiangji Wu,Hao Kong,Wenting Liao,Hong Jiang,Junbin Qian,Da Wang,Yun-Hua Liu

DOI: https://doi.org/10.1158/2159-8290.25191542

2024-01-01

Abstract:Supplementary Table S1. MAGeCK analysis of CRISPR screen results to identify regulator of immune evasion in orthotopic PDAC mouse models.
Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Xuebo Chen,Leying Zhang,Ian Y. Zhang,Junling Liang,Huaqing Wang,Mao Ouyang,Shihua Wu,Anna Carolina Carvalho da Fonseca,Lihong Weng,Yasuhiko Yamamoto,Hiroshi Yamamoto,Rama Natarajan,Behnam Badie

DOI: https://doi.org/10.1158/0008-5472.22402854

2023-01-01

Abstract:<p>Supplementary Table 1: Primers used in the real-time quantitative PCR.</p>
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Wenhua Sang,Yiduo Zhou,Haiyan Chen,Chengxuan Yu,Lisi Dai,Zhongkun Liu,Lang Chen,Yimin Fang,Panpan Ma,Xiangji Wu,Hao Kong,Wenting Liao,Hong Jiang,Junbin Qian,Da Wang,Yun-Hua Liu

DOI: https://doi.org/10.1158/2159-8290.25191539

2024-01-01

Abstract:Supplementary Table S2. Detailed information of human pancreatic tissue array.
Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu‐Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229782.v1

2023-01-01

Abstract:Supplementary Table S9. DE miRNAs in C2 (High) compared with C1 (Low).
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Wenhua Sang,Yiduo Zhou,Haiyan Chen,Chengxuan Yu,Lisi Dai,Zhongkun Liu,Lang Chen,Yimin Fang,Panpan Ma,Xiangji Wu,Hao Kong,Wenting Liao,Hong Jiang,Junbin Qian,Da Wang,Yun-Hua Liu

DOI: https://doi.org/10.1158/2159-8290.25183960

2024-01-01

Abstract:Supplementary Table S4. Primers used for qPCR or generating knockout/knockdown constructs.
Supplementary Figure S5 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142129

2024-01-01

Abstract:Supplementary Figure S5. Correlation of a Human DC_Ccl22 Homolog Score and CCL22 expression among multiple TCGA cohorts
Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229797.v1

2023-01-01

Abstract:Supplementary Table S5. DE genes in C2 (High) compared with C3 (Moderate).
Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142111

2024-01-01

Abstract:Supplementary Figure S9. Changes in gene expression associated with ISG + cDC2 among sequencing results
Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu‐Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229833

2023-01-01

Abstract:Supplementary Table S1. PCR primers of the 10 genes in the subnetwork for cell line experiments.
Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu‐Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229830

2023-01-01

Abstract:Supplementary Table S10. Survival analysis for DEmiRNA.
Supplementary Table S7 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229788.v1

2023-01-01

Abstract:Supplementary Table S7. KEGG analysis for DE genes between C1(Low) and High(C2).
Supplementary Table S17 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu‐Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229809

2023-01-01

Abstract:Supplementary Table S17. CD4+/CD8+ T cells infiltration levels in tumor tissues of mice bearing with S180.
Supplementary Figure S4 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142132

2024-01-01

Abstract:Supplementary Figure S4. Human expression of FOXP3 with RT and correlation with a Human DC_Ccl22 Homolog Score among TCGA cohorts
Supplementary Figure S3 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142135

2024-01-01

Abstract:Supplementary Figure S3. Changes in MC38 tumor cDC populations after local RT.
Supplementary Table S5 from CD38-Mediated Immunosuppression As a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Limo Chen,Lixia Diao,Yongyi Yang,Xiaohui Yi,B. Leticia Rodriguez,Yanli Li,Pamela Villalobos,Tina Cascone,Xi Liu,Tao Lin,Philip L. Lorenzi,Anfei Huang,Qiang Zhang,Di Peng,Jared J. Fradette,David H. Peng,Christin Ungewiss,Jonathon D. Roybal,Pan Tong,Junna Oba,Ferdinandos Skoulidis,Weiyi Peng,Brett W. Carter,Carl M. Gay,Fan Yu,Caleb A. Class,Jianxin Zhu,Jaime Rodriguez‐Canales,Masanori Kawakami,Lauren A. Byers,Scott E. Woodman,Vassiliki A. Papadimitrakopoulou,Ethan Dmitrovsky,Jing Wang,Stephen E. Ullrich,Ignacio I. Wistuba,John V. Heymach,F. Xiao-Feng Qin,Don L. Gibbons

DOI: https://doi.org/10.1158/2159-8290.22532336.v1

2023-01-01

Abstract:The ranked gene list for GSEA.
Supplementary Figure S6 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Jason Bugno,Liangliang Wang,Xianbin Yu,Xuezhi Cao,Jiaai Wang,Xiaona Huang,Kaiting Yang,Andras Piffko,Katherine Chen,Stephen Y. Luo,Emile Naccasha,Yuzhu Hou,Sherry Fu,Chuan He,Yang-xin Fu,Hua L. Liang,Ralph R. Weichselbaum

DOI: https://doi.org/10.1158/1078-0432.27142126

2024-01-01

Abstract:Supplementary Figure S6. Treg tumor infiltration after local RT in MC38 tumors and splenic cDC isolation strategy.
Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229824

2023-01-01

Abstract:Supplementary Table S12. MREs between mRNAs and miRNAs in the survival-related ceRNA network.

Supplementary Table S1 from RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Supplementary Table S2 from RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Supplementary Figures S1 to S6 from RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Supplementary Table S1 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Supplementary Table S2 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Figure S5 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table S7 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table S17 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Figure S4 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Figure S3 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Table S5 from CD38-Mediated Immunosuppression As a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Supplementary Figure S6 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance

Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma